POLD3

POLD3 is an essential regulatory subunit of DNA polymerase δ that stabilizes the entire Pol δ complex and couples replicative and repair-associated DNA synthesis to PCNA-loaded primer-template junctions (PMID:10852724, PMID:27524497). Originally purified as the p68/PCNA-binding subunit of the Pol δ holoenzyme (PMID:10852724), POLD3 engages PCNA through a strictly canonical PIP motif in which a conserved glutamine inserts into the Q-pocket and hydrophobic residues anchor the interaction (PMID:38223238). Its integrity is required to maintain the levels of POLD1, POLD2, and POLD4, so that loss of POLD3 destabilizes the whole complex; this dependence is recapitulated in mice, where POLD3 is essential for development and its loss causes replication stress aggravated by oncogenes (PMID:27524497), and in human patients, where a POLD3 variant that abolishes the protein collapses POLD1/POLD2 levels and underlies severe combined immunodeficiency with neurodevelopmental delay and hearing loss (PMID:37030525). Beyond bulk replication, POLD3 drives DNA damage tolerance and recombination-based synthesis: it promotes Pol δ holoenzyme extension past abasic sites in translesion synthesis (PMID:25628356) and interacts with the Rev1 C-terminal domain through a high-affinity RIR motif to facilitate polymerase switching during Rev1/Pol ζ-dependent TLS (PMID:26982350). POLD3 is the polymerase that executes break-induced replication (BIR) at stalled forks, telomeres, and transcription-associated double-strand breaks, where it is recruited downstream of RAD52 and R-loop/DNA:RNA-hybrid intermediates and acts together with BLM helicase (PMID:31777915, PMID:35440629). Activation of POLD3 for BIR requires site-specific PARP1/PARP2-mediated serine ADP-ribosylation downstream of Mre11/ATM, which promotes RAD52 assembly and fork recovery (PMID:37463936), while at ALT telomeres its stability is maintained by ATR-phosphorylated NPM1 within a CST/NPM1/POLD3 axis (PMID:41695477). Through these recombination-coupled synthesis functions, POLD3 suppresses R-loop-associated genome instability (PMID:27974823) and enables large-scale DSB-induced genomic amplification in cancer cells [PMID:bio_10.1101_2024.08.27.609980].

1. 2000 High

   Established the molecular identity of POLD3 as a genuine subunit of the Pol δ holoenzyme, answering whether the p68 protein was integral to the replicative polymerase and how it links to processivity machinery.

   Evidence Immunoaffinity purification, gel filtration, glycerol gradients, PCNA overlay, and protein sequencing of the human Pol δ complex

   PMID:10852724

   Open questions at the time

   • Did not define the functional consequence of PCNA binding
   • No structural detail of the PCNA interaction
2. 2015 High

   Showed POLD3 has a translesion synthesis function beyond its role in Pol ζ, addressing whether the Pol δ subunit itself contributes to lesion bypass.

   Evidence DT40 gene knockouts with UV survival, fork progression, mutagenesis assays, and in vitro abasic-site bypass with Pol δ holoenzyme

   PMID:25628356

   Open questions at the time

   • Chicken cell model; human relevance not directly tested here
   • Mechanism distinguishing Pol δ- versus Pol ζ-dependent bypass unresolved
3. 2016 High

   Defined the structural basis by which POLD3 connects to the Rev1 TLS scaffold, explaining how it could mediate polymerase switching during damage bypass.

   Evidence NMR structure and binding-affinity measurement of the Rev1-CT/PolD3-RIR complex

   PMID:26982350

   Open questions at the time

   • Switching model inferred from affinity, not directly observed on DNA
   • In-cell requirement of the RIR motif not tested
4. 2016 Medium

   Linked POLD3 to suppression of R-loop-associated genome instability, showing its loss produces breaks and replication defects dependent on RNA-DNA hybrids.

   Evidence siRNA depletion in human cells with γH2AX, fiber assays, anaphase-bridge counts, and RNase H rescue

   PMID:27974823

   Open questions at the time

   • Single lab; mechanism of R-loop resolution versus tolerance not separated
   • Extent attributable to Pol ζ versus Pol δ unclear
5. 2016 High

   Demonstrated POLD3 is essential in vivo and stabilizes the entire Pol δ complex, establishing why its loss is incompatible with normal replication.

   Evidence Knockout mice with Mendelian-ratio analysis, oncogene expression, and western blotting of Pol δ subunit stability

   PMID:27524497

   Open questions at the time

   • Did not separate replication-stability role from repair roles in the phenotype
   • Mechanism of subunit destabilization not defined
6. 2018 High

   Extended POLD3's essential role to DSB repair and telomere maintenance, connecting it to 53BP1/RIF1/ATR/ATM signaling in embryonic and germline cells.

   Evidence CRISPR/TALEN knockout mice and inducible KO ESCs with telomere FISH, fiber assays, and pathway western blots

   PMID:29447390

   Open questions at the time

   • Whether POLD3 acts directly in these pathways or indirectly via replication stress unresolved
   • Direct molecular partners at telomeres not identified here
7. 2020 High

   Ordered a telomeric DSB repair pathway in which RAD52 recruits POLD3 to drive BIR at R-loop-bearing damaged telomeres, defining the CSB-RAD52-POLD3 axis.

   Evidence Reciprocal co-IP, PLA, RNase H treatment, siRNA depletion, telomere FISH, and live-cell imaging

   PMID:31777915

   Open questions at the time

   • Direct POLD3-RAD52 physical contact versus indirect recruitment not fully delineated
   • Generalizability beyond ROS-induced telomeric breaks unknown
8. 2021 Medium

   Provided functional evidence that POLD3 accelerates DSB repair initiation, exploited by fusing it to Cas9 to enhance HDR editing.

   Evidence Systematic screen of 450 DNA-repair-Cas9 fusions with HDR efficiency quantification across loci and cell types

   PMID:34898428

   Open questions at the time

   • Mechanism of repair-initiation speed-up not molecularly resolved
   • Engineering result; endogenous POLD3 timing not directly measured
9. 2022 Medium

   Identified a POLD3-dependent repair synthesis pathway at transcription-associated DSBs acting with BLM helicase under excess RNA:DNA hybrids.

   Evidence siRNA depletion, EdU incorporation at DSBs, RNase H overexpression, and viability assays in human cells

   PMID:35440629

   Open questions at the time

   • Epistasis order of BLM and POLD3 not fully resolved
   • Whether this is the same BIR machinery as at telomeres not established
10. 2023 High

    Defined how POLD3 is switched on for BIR, identifying PARP1/2 serine ADP-ribosylation downstream of Mre11/ATM as the activating modification.

    Evidence MS site-mapping of ADP-ribosylation, PARP/Mre11/ATM inhibition, site mutants, fork and BIR reporter assays

    PMID:37463936

    Open questions at the time

    • How ADP-ribosylation changes POLD3 activity biochemically not resolved
    • Reader/eraser of the mark not identified
11. 2023 High

    Resolved the atomic basis of POLD3's PCNA engagement, confirming a strictly canonical PIP-box mode.

    Evidence X-ray crystallography of the PolD3 PIP peptide-PCNA complex and ITC affinity measurement

    PMID:38223238

    Open questions at the time

    • Ortholog (C. thermophilum) peptide used
    • Functional consequence of disrupting this contact in cells not tested here
12. 2023 Medium

    Confirmed in human patients that POLD3 is required for Pol δ complex stability and linked its deficiency to a defined immunodeficiency syndrome.

    Evidence Exome sequencing and western blotting of POLD1/POLD2/POLD3 in patient-derived cells

    PMID:37030525

    Open questions at the time

    • Single case; genotype-phenotype causality not established by rescue
    • Mechanism linking Pol δ loss to immune and neurodevelopmental phenotypes unexplored
13. 2024 Medium

    Placed POLD3 as an essential effector of DSB-induced genomic amplification, connecting its BIR function to oncogenic copy-number gains.

    Evidence POLD3 deletion/depletion in cancer cells with copy-number assays and epistasis with RAD52, POLD4, RAD51 (preprint)

    PMID:bio_10.1101_2024.08.27.609980

    Open questions at the time

    • Preprint; not peer-reviewed
    • Single lab and single method per claim
14. 2025 Medium

    Uncovered a genetic interaction placing POLD3 within replication-coupled UV-damage tolerance relative to WRNIP1.

    Evidence Auxin-degron double knockouts in DT40 with UV survival, CPD slot-blot, and SCE quantification

    PMID:41319413

    Open questions at the time

    • Chicken cell model
    • Direct biochemical relationship between POLD3 and WRNIP1 not defined
15. 2026 Medium

    Defined a post-translational stabilization axis controlling POLD3 abundance at ALT telomeres through ATR-phosphorylated NPM1 and CST.

    Evidence Co-IP, ubiquitination assays, NPM1 T199A rescue, ATR inhibition, and BITR/telomere FISH in ALT osteosarcoma cells

    PMID:41695477

    Open questions at the time

    • E3 ligase targeting POLD3 not identified
    • Specificity to ALT-positive versus telomerase-positive cells unresolved

• How POLD3's distinct activities — replicative Pol δ subunit, TLS facilitator, and BIR effector — are partitioned and regulated at the level of complex composition and post-translational modification remains unresolved.
• No structure of full-length POLD3 within Pol δ or Pol ζ
• Biochemical effect of ADP-ribosylation on polymerase activity unknown
• Mechanism switching POLD3 between canonical replication and BIR not defined